Note: Ingredients listed on restricted chemical lists
EC/CAS
233-139-2/10043-35-3
Name of the chemical
Borsäure Borsäure
Concentration
15-40
EC/CAS
231-548-0/7631-90-5
Name of the chemical
Sodium hydrogensulphite; Sodium bisulphite
Concentration
1-5
EC/CAS
9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
1-5
EC/CAS
264-151-6/63449-41-2
Name of the chemical
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides
Concentration
<0.1
General Information
Version
10
Revision date
2018-10-02
Product name
Pred Forte
Product Synonyms
Prednisolone Acetate
1.2.1 Relevant identified uses
Corticosteroid This safety data sheet is written to provide health, safety and environmental information for people handling this formulated product in the workplace. It is not intended to provide information relevant to medicinal use of the product. In this instance patients should consult prescribing information/package insert/product label or consult their pharmacist or physician. For health and safety information for individual ingredients used during manufacturing, refer to the appropriate safety da...
Manufacturer Name
Allergan plc
Emergency telephone
1-800-424-9300, +1-703-741-5970
Icons in SDS
Company Information
company name
Allergan plc
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@Allergan.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H361
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
OSHA Hazards Classification
2.2 Label elements
Emergency Overview Danger
Hazard statements
H362 - May cause harm to breast-fed children H361 - Suspected of damaging fertility or the unborn child (Bad file name) Appearance Liquid Chemical Name Prednisolone acetate Physical state Liquid Odor No information available Symptoms Adverse reactions have occurred with corticosteroid/antibacterial combination drugs which can be attributed to the corticosteroid component, the antibacterial component, or the combination. Exact incidence figures are not available since no denominator of treated patients is available. Reactions occurring most often from the presence of the antibacterial ingredient are allergic sensitizations. Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias. Sulfacetamide sodium may cause local irritation.The reactions due to the corticosteroid component in decreasing order of frequency are: elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing. Although systemic effects are extremely uncommon, there have been rare occurrences of systemic hypercorticoidism after use of topical corticosteroids. Corticosteroid-containing preparations can also cause acute anterior uveitis or perforation of the globe. Mydriaisis, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. Secondary Infection The development of secondary infection has occurred after use of combinations containing corticosteroids and antibacterials. Fungal and viral infections of the cornea are particularly prone to develop coincidentally with long-term applications of corticosteroid. The possibility of fungal invasion must be considered in any persistent corneal ulceration where corticosteroid treatment has been used. Secondary bacterial ocular infection following suppression of host responses also occurs. Chemical Name Prednisolone acetate
Medical Conditions Generally Aggravated by Exposure
This ophthalmic ointment is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.This product is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation, to other sulfonamides and to other corticosteroids. (Hypersensitivity to the antimicrobial component occurs at a higher rate than for other components.) Polysorbate 80 Hypersensitivity to the material.
Precautionary statements
P302 + P352 - IF ON SKIN Wash with plenty of soap and water P321 - Specific treatment (see supplemental first aid instructions on this label) P332 + P313 - If skin irritation occurs Get medical advice/attention P362 - Take off contaminated clothing and wash before reuse P337 + P313 - If eye irritation persists: Get medical advice/attention P202 - Do not handle until all safety precautions have been read and understood P405 - Store locked up P501 - Dispose of contents/ container to an approved waste disposal plant P280 - Wear protective gloves/protective clothing/eye protection/face protection P201 - Obtain special instructions before use P260 - Do not breathe dust/fume/gas/mist/vapors/spray P263 - Avoid contact during pregnancy/while nursing P264 - Wash face, hands and any exposed skin thoroughly after handling P270 - Do not eat, drink or smoke when using this product
Further information
Unknown Acute Toxicity 17.7% of the mixture consists of ingredient(s) of unknown toxicity
2.1 Classification of the substance or mixture
OSHA Regulatory Status This chemical is considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200) Reproductive toxicity Category 2 Effects on or via lactation Yes